La biopsie liquide est un test non invasif principalement utilisé comme outil de diagnostic ou de surveillance des maladies, y compris le cancer.
- Diagnostic du cancer
- Pour suivre et contrôler l’effet d’un traitement
- Diagnostic
- Choix du traitement
- Test prénatal non invasif
Origine des prélèvements des Biopsies liquides. Plusieurs fluides physiologiques peuvent contenir des produits génétiques dérivés des tumeurs.
Source by Springer Nature Limited, 2017.
BioChain
Founded in 1994, BioChain is headquartered in the San Francisco Bay Area.
BioChain is the world leader in high quality processed bio-sample products and analysis services used in advancing translational medicine, companion diagnostics, and clinical product research and development.
In addition to our world-class bio-specimen and sample preparation line of business, BioChain is moving into the clinical applications that offer clinical genomics diagnostics products and clinical trial services in cancer and reproductive health.
BioChain established a comprehensive quality assurance program to meet our customers’ satisfactions as well as maintaining both ISO9001:2015 and ISO 13485:2016 certifications for our in house production facilities.
Innovation and Collaboration:
As an industry leader, BioChain is always striving to innovate and collaborate with the world’s leading Pharmaceutical, Bio Technology, and Health Care organizations.